WO2010046804A3 - A process for preparation of losartan potassium form i - Google Patents

A process for preparation of losartan potassium form i Download PDF

Info

Publication number
WO2010046804A3
WO2010046804A3 PCT/IB2009/054485 IB2009054485W WO2010046804A3 WO 2010046804 A3 WO2010046804 A3 WO 2010046804A3 IB 2009054485 W IB2009054485 W IB 2009054485W WO 2010046804 A3 WO2010046804 A3 WO 2010046804A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
losartan potassium
potassium form
losartan
relates
Prior art date
Application number
PCT/IB2009/054485
Other languages
French (fr)
Other versions
WO2010046804A2 (en
Inventor
Ravi Ponnaiah
Sanjay Desai
Dhiraj Rathod
Chirag Parikh
Original Assignee
Alembic Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Limited filed Critical Alembic Limited
Publication of WO2010046804A2 publication Critical patent/WO2010046804A2/en
Publication of WO2010046804A3 publication Critical patent/WO2010046804A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a process for preparation of Losartan potassium Form I.
PCT/IB2009/054485 2008-10-21 2009-10-13 A process for preparation of losartan potassium form i WO2010046804A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2265MU2008 2008-10-21
IN2265/MUM/2008 2008-10-21

Publications (2)

Publication Number Publication Date
WO2010046804A2 WO2010046804A2 (en) 2010-04-29
WO2010046804A3 true WO2010046804A3 (en) 2010-11-04

Family

ID=42119764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/054485 WO2010046804A2 (en) 2008-10-21 2009-10-13 A process for preparation of losartan potassium form i

Country Status (1)

Country Link
WO (1) WO2010046804A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150090265A (en) * 2013-02-28 2015-08-05 미쓰이금속광업주식회사 Blackened surface-treated copper foil, method for manufacturing blackened surface-treated copper foil, copper-clad laminate and flexible printed circuit board

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094816A1 (en) * 2001-05-18 2002-11-28 Aurobindo Pharma Limited Process for the crystallization of losartan potassium
WO2005021535A2 (en) * 2003-08-27 2005-03-10 Zentiva, A.S. A method of removing the triphenylmethane protecting group
WO2007020654A1 (en) * 2005-08-16 2007-02-22 Suven Life Sciences An improved process for the preparation of losartan

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094816A1 (en) * 2001-05-18 2002-11-28 Aurobindo Pharma Limited Process for the crystallization of losartan potassium
WO2005021535A2 (en) * 2003-08-27 2005-03-10 Zentiva, A.S. A method of removing the triphenylmethane protecting group
WO2007020654A1 (en) * 2005-08-16 2007-02-22 Suven Life Sciences An improved process for the preparation of losartan

Also Published As

Publication number Publication date
WO2010046804A2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
WO2011138281A3 (en) Process for the preparation of dithiine tetracarboxydiimides
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2012061607A3 (en) Compositions comprising functionalized carbon-based nanostructures and related methods
WO2010102980A9 (en) Process for preparing substituted 2-nitrobiphenyls
WO2011019986A3 (en) Processes for preparing pemetrexed
WO2010028122A8 (en) Process for making bivalirudin
WO2010129211A3 (en) Preparation of decitabine
EP2280039B8 (en) Process for production of polysilane compound
WO2011004402A3 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
WO2011157390A3 (en) Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
PL2343292T3 (en) Novel prostaglandin i2 derivative
WO2011015287A3 (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2008075205A3 (en) Improved process for the preparation of voriconazole
EP2090567A3 (en) Processes for the preparation of intermediates of valsartan
UA106988C2 (en) A method of obtaining of 1-benzyl-3-hydroxymethyl-1h-indazole and its derivatives and required intermediate magnesium compounds
WO2013076743A3 (en) Process for the purification of polyaminocarboxylates
EP2344468A4 (en) Process for the preparation of ramelteon
ZA201006669B (en) Process for the preparation of synthesis gas,ii
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2011018771A3 (en) Process for the preparation of valganciclovir hydrochloride
WO2010018441A3 (en) Process for the preparation of substantially pure telmisartan
WO2009116081A3 (en) An improved process for the preparation of aprepitant
WO2008094617A3 (en) Crystalline forms of deferasirox
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09821672

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09821672

Country of ref document: EP

Kind code of ref document: A2